Joanna M. Joly
YOU?
Author Swipe
View article: Thrombolysis in spontaneous coronary artery dissection: a case report of acute catastrophic dissection requiring coronary artery bypass surgery and delayed heart transplant in a young woman with fibromuscular dysplasia
Thrombolysis in spontaneous coronary artery dissection: a case report of acute catastrophic dissection requiring coronary artery bypass surgery and delayed heart transplant in a young woman with fibromuscular dysplasia Open
Background Spontaneous coronary artery dissection (SCAD) is a rare condition characterized by a tear in the coronary artery wall and is often associated with fibromuscular dysplasia (FMD). It is unclear whether SCAD with FMD represents a p…
View article: BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension Open
NCT03950739.
View article: Breastfeeding Practices in Patients with Heart Disease Stratified by Area Deprivation Index
Breastfeeding Practices in Patients with Heart Disease Stratified by Area Deprivation Index Open
Objective: We sought to evaluate breastfeeding (BF) practices in patients with maternal cardiac disease (MCD) stratified by area deprivation index (ADI) to identity communities at risk. Study Design: Retrospective cohort of patients manage…
View article: Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience
Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience Open
ECMO use in peripartum patients in a single tertiary center was associated with a high survival rate. Furthermore, a strong multidisciplinary team, careful reevaluation of clinical trajectory, and consideration of complications and risks a…
View article: Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality Open
Objective A post-hoc analysis of the INCREASE trial and its open-label extension (OLE) was performed to evaluate whether inhaled treprostinil has a long-term survival benefit in patients with pulmonary hypertension associated with intersti…
View article: The role of comorbidities, medications, and social determinants of health in understanding urban‐rural outcome differences among patients with heart failure
The role of comorbidities, medications, and social determinants of health in understanding urban‐rural outcome differences among patients with heart failure Open
Purpose There is now a 20% disparity in all‐cause, excess deaths between urban and rural areas, much of which is driven by disparities in cardiovascular death. We sought to explain the sources of these disparities for Medicare beneficiarie…
View article: Breastfeeding practices among patients managed by a comprehensive cardio-obstetrics program
Breastfeeding practices among patients managed by a comprehensive cardio-obstetrics program Open
Objective: To evaluate breastfeeding intent, rates at discharge, and continued breastfeeding at follow-up in patients managed in a comprehensive cardio-obstetrics program stratified by severity of maternal cardiac disease.Study Design: Ret…
View article: Breastfeeding practices among patients managed by a comprehensive cardio-obstetrics program
Breastfeeding practices among patients managed by a comprehensive cardio-obstetrics program Open
Objective: To evaluate breastfeeding intent, rates at discharge, and continued breastfeeding at follow-up in patients managed in a comprehensive cardio-obstetrics program stratified by severity of maternal cardiac disease. Study Design: Re…
View article: BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension Open
Inhaled treprostinil is an approved therapy for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease in the United States. Studies have confirmed the robust benefits and safety of nebul…
View article: Giant-cell myocarditis management using short-term TandemHeart support, MANTA closure device, and combination immunosuppression
Giant-cell myocarditis management using short-term TandemHeart support, MANTA closure device, and combination immunosuppression Open
We present the case of a 53-year-old woman who presented to the hospital with palpitations and fatigue. The workup revealed new-onset systolic heart failure secondary to giant cell myocarditis. She developed cardiogenic shock, which was ma…
View article: Commentary: Vita brevis, ars longa, iudicium difficile
Commentary: Vita brevis, ars longa, iudicium difficile Open
The full quote of Hippocrates (Greek physician circa 400 B.C.E.) translated from Latin to English is “Life is short, art long, opportunity fleeting, experience treacherous, judgment difficult.” The present case report exemplifies some of t…
View article: Persistent mitral regurgitation after left ventricular assist device: a clinical conundrum
Persistent mitral regurgitation after left ventricular assist device: a clinical conundrum Open
Aims Persistent mitral valve regurgitation (MR) after continuous flow left ventricular assist device implantation (cfLVAD) is associated with pulmonary hypertension and right ventricular failure with variable effects on survival across pub…
View article: Cryoablation during left ventricular assist device implantation: A case report
Cryoablation during left ventricular assist device implantation: A case report Open
Central MessageEndomyocardial cryoablation during an LVAD implant is an option for patients with end-stage heart failure who have refractory VT. More studies are needed to evaluate this strategy.See Commentaries on pages 58 and 60. Endomyo…